Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

522 Postmarket Surveillance Studies Database
  • Print
  • Share
  • E-mail
-
The FDA has the authority to require device manufacturers to perform postmarket surveillance under Section 522 of the Food, Drugs and Cosmetics (FD&C) Act, when questions are identified for devices that meet the statutory criteria. This database contains information about 522 Postmarket Surveillance Studies that have been required. This database allows you to search information about the postmarket surveillance requirements by manufacturer or device.

Learn more...

            
  To search for Manufacturer beginning with a specific letter, select that letter
 
 A 
 B 
 C 
 D 
 E 
 F 
 G 
 H 
 I 
 J 
 L 
 M 
 N 
 O 
 P 
 R 
 S 
 T 
 U 
 V 
 W 
 X 
 Z 
 
 
  19 orders  
  Active Orders
Suggest Enhancement / Report Issue | export reports to excelExport to Excel
Sort By 522 Order Number 522
Order
Number		 Sort By 522 Order Number -- Descending
Sort By Manufacturer Manufacturer Sort By Manufacturer -- Descending
   Sort By Device Name Device
Name		 Sort By Device Name -- Descending
Medical
Specialty
Sort By Date 522 Order Date 522
Order		 Sort By Date 522 Order -- Descending
Study
Name
Study Status
PS210001 Abbott Diabetes Care Inc. Freestyle libre 2 flash glucose monitoring system Clinical Chemistry 02/18/2021 Postmarket Surveillance Delayed
PS140001 Argo Medical Technologies, Inc Rewalk Neurology 06/26/2014 ReWalk Registry Redesigned/Replaced Study
PS200001 Avenu Medical, Inc. Ellipsys vascular access system Cardiovascular 01/10/2020 Ellipsys Vascular Access System PS Study Ongoing
PS160001 Bayer Healthcare, LLC Essure system for permanent birth control Obstetrics/
Gynecology		 02/29/2016 Postmarket Surveillance Study Progress Inadequate
PS200004 Bluegrass Vascular Technologies, Incorporated Surfacer inside-out access catheter system Cardiovascular 02/10/2020 Postmarket Surveillance Study Progress Adequate
PS200005 Caldera Medical, Inc. Desara One Single Incision Sling System Gastroenterology/
Urology		 02/11/2020 Postmarket Surveillance Study Ongoing
PS220001 Canary Medical, Inc. Canary health implanted reporting processor Orthopedic 01/24/2022 Study of Subjects with the CTE Tibial Extension Study Pending
PS200006 Medtronic, Inc. Carpediem Gastroenterology/
Urology		 04/29/2020 CARPEDIEM 522 Progress Inadequate
PS110070 MicroPort Metal transcend articulation system Orthopedic 05/06/2011 Metal Ion Levels Wright Redesigned/Replaced Study
PS110002 Nexus CMF Tmj fossa-eminence/condylar prosthesis system Dental 02/04/2011 Registry Database Redesigned/Replaced Study
TMJM Registry Study - Partial Redesigned/Replaced Study
Prospective Postmarket Surveillance Study Plan Progress Inadequate
Explant Analysis Study Plan Progress Adequate
PS200003 Olympus America, Inc. Evis exera iii duodenovideoscope tjf-q190v Gastroenterology/
Urology		 01/17/2020 Sampling and Culturing Study Progress Inadequate
PS160003 Parker Hannifin Corporation Indego Neurology 04/15/2016 Indego Postmarket Surveillance Study Progress Inadequate
PS210002 Pentax Pentax ed32-i10 duodenoscope Gastroenterology/
Urology		 04/01/2021 Postmarket Surveillance (PS) Study Ongoing
PS190005 Pentax of America, Inc. Pentax duodenoscope model ed34-il0t2 Gastroenterology/
Urology		 11/15/2019 Sampling and Culturing Study Delayed
PS190001 Rapid-Medical, Ltd. Comaneci embolization assist device Neurology 05/22/2019 Success in Comaneci-assist Coils Embolization Surv Ongoing
PS190006 Tandem Diabetes Co. Control-iq, algorithm Clinical Chemistry 12/13/2019 Postmarket Surveillance Study Progress Adequate
PS200008 Tandem Diabetes Co. Control-iq technology Clinical Chemistry 06/23/2020 Postmarket Surveillance Progress Adequate
PS110003 TMJ Concepts Patient-fitted tmj reconstruction prosthesis system Dental 02/04/2011 Time to Revision and Explant Analysis Progress Adequate
PS180002 TVA Medical, Inc. Wavelinq endoavf system Cardiovascular 06/22/2018 WavelinQ endoAVF Progress Adequate


Contact Us

Mandated Studies Program
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Email: MandatedStudiesPrograms@fda.hhs.gov

Additional Resources
-
-